ProteomesCancer BiologyPeer-reviewed journal article
Integrative Proteomic Analysis Implicates Inhibition of Intracellular Protein Trafficking in Therapy-Induced Migrastasis in Prostate Cancer
Weining CheniD, Saadyeh Rashidi, Henry C.-H. LawiD, Fangfang QiaoiD, Johnny W. Zigmond, Katelyn L. O’NeilliD, Nicholas T. WoodsiD, Chittibabu GudaiD, Raymond C. BerganiD
Abstract
BackgroundDysregulated cell migration leading to metastasis remains the primary cause of cancer-related mortality. It has been challenging to understand how cells regulate migration. We have previously created the first selective inhibitor of cell migration, KBU2046. Here, we use it as a probe to identify regulatory processes. MethodsMetastatic and primary human prostate cancer cells were treated for different times and at different concentrations with KBU2046. Immunofluorescent microscopy examined protein localization in cells. Label-free mass spectrometry (MS) was performed on total cell proteins, Tandem Mass Tag (TMT) labeling MS was used on membrane fractions, and temporal phosphoproteomic profiling. Results were analyzed with a suite of bioinformatic tools. ResultsKBU2046-induced migrastasis is associated with the accumulation of activated integrin {beta}1 into focal adhesions. Whole-cell proteomics demonstrated suppression of processes that mediate intracellular protein trafficking and increases in mitochondrial energy-generation signatures. Evaluation of the membrane fraction identified increases in membrane repair and maintenance processes and decreases in those that drive motility. Temporal- and concentration-dependent phosphoproteomic profiling revealed that KBU2046 initiates a dynamic, cascading sequence of transient signaling waves rather than a static block. ConclusionsKBU2046-induced migrastasis appears to operate through spatial decoupling rather than structural degradation. By restricting the intracellular trafficking machinery required for receptor recycling, KBU2046 limits focal adhesion turnover, providing a correlative framework to inhibit metastatic dissemination independent of direct cytotoxicity. O_FIG O_LINKSMALLFIG WIDTH=122 HEIGHT=200 SRC="FIGDIR/small/736165v1_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@1efd74dorg.highwire.dtl.DTLVardef@1202106org.highwire.dtl.DTLVardef@581ed3org.highwire.dtl.DTLVardef@14fdcfb_HPS_FORMAT_FIGEXP M_FIG Graphic Abstract C_FIG
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 49th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CD155 and EndoA1 mediate growth and tissue invasion downstream of MAP4K4 in medulloblastoma cells
C. Capdeville, L. Russo, … M. Baumgartner·bioRxiv·Aug 10, 2021
- Protein kinase D promotes prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK/ERK1/2-dependent manner
- Tumor Protein D54 (TPD54) regulates intracellular protein trafficking, cellular function and disease progression in melanoma
Michael Ortiz, Charlie B. Ffrench, … Claudine S. Bonder·bioRxiv·May 12, 2026
- Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer
G. Zhao, G. Forn-Cuni, … E. B. Snaar·bioRxiv·Aug 14, 2023
- PBF/PTTG1IP coordinates focal adhesion formation, polarity and cell motility
Merve Kocbiyik, Selvambigai Manivannan, … Vicki E. Smith·bioRxiv·Sep 16, 2026
- MAP4K4 regulates biomechanical forces at adherens junctions and focal adhesions to promote collective cell migration
L. E. Alberici Delsin, C. Plutoni, … G. Emery·bioRxiv·Nov 22, 2022